发明名称 Herpes virus complementing cell line
摘要 The present invention is directed to a cell line capable of supporting replication of a growth-defective Herpes Simplex Virus strain; specifically a replication-defective HSV-2 double mutant. Particularly disclosed is a cell line that expresses the ICP8 protein and the UL5 protein of Herpes Simplex Virus. This cell line is useful to propagate a replication-defective HSV-2 vaccine strain that contains mutations and/or deletions in the ICP8 and UL5 genes.
申请公布号 US6841373(B2) 申请公布日期 2005.01.11
申请号 US20020257229 申请日期 2002.10.10
申请人 AVANT IMMUNOTHERAPEUTICS, INC. 发明人 METCALFE KAREN
分类号 A61K39/245;A61P31/22;C07K14/035;C12N5/10;C12N7/01;C12N7/04;(IPC1-7):C12N5/10 主分类号 A61K39/245
代理机构 代理人
主权项
地址